
Alendronate is one of a few pharmaceutical agents that have evidence to protect both vertebral and non-vertebral fracture. Here I review its effects on fracture prevention, as well as on surrogate markers such as bone mineral density, height loss, metabolic bone markers. Its effects on activities of daily living and quality of life will also be touched upon.
Male, Evidence-Based Medicine, Alendronate, Bone Density Conservation Agents, Fractures, Bone, Bone Density, Activities of Daily Living, Quality of Life, Humans, Osteoporosis, Female, Randomized Controlled Trials as Topic
Male, Evidence-Based Medicine, Alendronate, Bone Density Conservation Agents, Fractures, Bone, Bone Density, Activities of Daily Living, Quality of Life, Humans, Osteoporosis, Female, Randomized Controlled Trials as Topic
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 0 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Average | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Average | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Average |
